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Abstract
Background: To date, the morbidity of urethral stricture disease among American men has not been analyzed
using national datasets. We sought to analyze the morbidity of urethral stricture disease by measuring the rates of
urinary tract infections and urinary incontinence among men with a diagnosis of urethral stricture.
Methods: We analyzed Medicare claims data for 1992, 1995, 1998, and 2001 to estimate the rate of dual diagnoses
of urethral stricture with urinary tract infection and with urinary incontinence occurring in the same year among a
5% sample of beneficiaries. Male Medicare beneficiaries receiving co-incident ICD-9 codes indicating diagnoses of
urethral stricture and either urinary tract infection or urinary incontinence within the same year were counted.
Results: The percentage of male patients with a diagnosis of urethral stricture who also were diagnosed with a
urinary tract infection was 42% in 2001, an increase from 35% in 1992. Eleven percent of male Medicare
beneficiaries with urethral stricture disease in 2001 were diagnosed with urinary incontinence in the same year.
This represents an increase from 8% in 1992.
Conclusions: Among male Medicare beneficiaries diagnosed with urethral stricture disease in 2001, 42% were also
diagnosed with a urinary tract infection, and 11% with incontinence. Although the overall incidence of stricture
disease decreased over this time period, these rates of dual diagnoses increased from 1992 to 2001. Our findings
shed light into the health burden of stricture disease on American men. In order to decrease the morbidity of
stricture disease, early definitive management of strictures is warranted.
Background
Although the true incidence of urethral stricture disease
in men is unknown, Medicare utilization rates for men
age 65 and over were 0.9% in 2001, a decrease from
1.4% in 1992 [1]. Utilization data from the Veteran
Affairs (VA) in 2003 revealed a prevalence rate of 193
per 100,000 diagnoses (0.2%) [2]. Urethral stricture dis-
ease imposes a great burden on both health and quality
of life in men. Previous studies of male urethral stricture
disease have shown that nearly 90% of men present with
complications [2]. The majority of men with a stricture
suffer from obstructive and irritative voiding symptoms,
and many experience hematuria, recurrent urinary tract
infections, and the need for repeated procedures such as
dilation or urethrotomy [2-5]. More severe complica-
tions, including acute urinary retention, urethral carci-
noma, renal failure, Fournier’s gangrene, and bladder
atonia have been reported in a small minority of men
with stricture disease [2].
The therapy for urethral strictures is also known to be
associated with complications that further amplify the
burden of disease. Investigations on complication rates
following urethrotomy have reported bleeding in 4-6%
of cases, infection in 8-9%, incontinence in 1%, and
impotence in 1% [5-7]. Additionally, strictures tend to
recur after urethrotomy or dilation, with success rates
varying based on stricture length and location [8,9].
Long-term success of dilation and urethrotomy for
longer strictures greater than two centimeters is less
than 35% [10]. Men whose strictures recur after a single
urethrotomy or dilation are almost invariably likely to
fail a second procedure [6,7]. Although definitive ure-
throplasty has a very high cure rate with acceptably low
morbidity, unfortunately this treatment modality is per-
formed infrequently [1].
To better understand the morbidity of urethral stric-
ture disease on American men, we used Medicare claims
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data in order to measure the true association of male
urethral stricture disease with both urinary tract infec-
tions and urinary incontinence.
Methods
And IRB exemption from UCLA was granted for this
project, as all data was de-identified. We analyzed Medi-
care claims data for 1992, 1995, 1998, and 2001 to esti-
mate the rate of dual diagnoses of urethral stricture
with urinary tract infection and with urinary inconti-
nence occurring in the same year. The datasets were
derived from the Centers for Medicare and Medicaid
Services (CMS) administrative records as a 5% random
sample, as previously described. Data from three Medi-
care files, including Medicare Provider Analysis and
Review (MEDPAR), carrier, and outpatient, were linked
to determine beneficiary use in the inpatient, ambula-
tory surgery center, hospital outpatient, physician office,
and emergency room settings. Estimates for disease pre-
valence were derived from these data files. For each
condition, International Classification of Diseases, 9th
Edition (ICD-9) codes for urethral stricture were applied
to analytical files from each of the above datasets [2].
Male Medicare beneficiaries receiving co-incident ICD-9
codes indicating diagnoses of urethral stricture and
either urinary tract infection or urinary incontinence
within the same year were counted. Denominators were
derived using the CMS enrollment file, which supplied
data on all Medicare beneficiaries enrolled in the years
analyzed. Results were stratified by age, race/ethnicity,
and geographic region. Because a 5% sample of Medi-
care records was used, estimates were obtained by mul-
tiplying counts by a constant weight of 20. The
methodology and analytical methods used to generate
these results have been described previously [11].
Results
The percentage of men with a diagnosis of urethral
stricture who were also diagnosed with urinary tract
infection in the same year increased from 35% in 1992
to 42% in 2001 (Additional file 1: Table S1). This asso-
ciation was seen across all age groups. Additionally, this
association was seen across all races analyzed, with the
largest association noted in Hispanic populations (52-
56%). Data was also stratified by location, and all regions
of the United States were noted to have comparable
associations between urethral stricture disease and urin-
ary tract infections.
There was also a significant association of urethral
stricture disease with urinary incontinence. Eleven per-
cent of male Medicare beneficiaries with urethral stric-
ture disease in 2001 were diagnosed with urinary
incontinence in the same year (Additional file 2: Table
S2). This represents an increase from 8% in 1992. This
association spanned all age ranges of male Medicare
beneficiaries, with increased associations seen with
increasing age. Among all races analyzed, Hispanics
with stricture disease had the highest rate of associated
urinary incontinence (18%). There was no regional var-
iation appreciated.
Discussion
Although urethral stricture disease is known to be asso-
ciated with other urologic conditions, the association of
urinary tract infection and urinary incontinence with
urethral strictures has been largely undefined in large
series. The data presented in this investigation provide
evidence of a strong association between male urethral
stricture disease and urinary tract infections, occurring
as a co-diagnosis in 41% of male Medicare beneficiaries.
The association between male urethral stricture disease
and urinary incontinence is also significant, as demon-
strated by a co-diagnosis in 11% of Medicare benefici-
aries with a diagnosis of urethral stricture disease.
An association of urinary tract infections with urethral
strictures has been previously documented. Romero
et al analyzed the presentation of 175 patients with ure-
thral stricture disease, of which sixty-three (36%) pre-
sented with urinary tract infection [12]. Urethral
strictures incite a condition of urinary stasis, of which
urinary tract infection is a known outcome secondary to
an increased post-void residual volume [12]. Frequent
instrumentation employed in the diagnosis and manage-
ment of urethral stricture disease is another potential
cause for infection, with introduction of organisms in a
retrograde fashion through the urethra, which may then
colonize the lower urinary tract.
The association between urethral strictures and urin-
ary incontinence has been previously documented but
not well quantified. Following procedures for proximal
bulbar urethral stricture disease adjacent to the external
sphincter, incontinence is a known potential adverse
outcome in men who have undergone previous proce-
dures involving the bladder neck, such as radical prosta-
tectomy, transurethral resection of the prostate, or
bladder neck incision. The reason for increasing rates of
both urinary tract infections and urinary incontinence
over the 1992-2001 time period may be due to new
treatments for BPH and prostate cancer that have a
more severe effect on the urethra.
Overall rates of stricture prevalence decreased over
the 1992-2001 time period, possibly due to lower rates
of infectious urethritis, as well as better cure rates of
long strictures with the use of urethroplasty with buccal
graft augmentation [2,13,14]. However, the rate of dual
diagnoses of stricture with UTI and incontinence
increased over this time period. This may possibly be
due to a shift in stricture characteristics toward a more
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aggressive stricture caused by one of many available
treatments for prostate cancer or BPH. Urethral stric-
ture disease occurs in up to 8.4% of men after treatment
for prostate cancer [15]. This includes men who
undergo radical prostatectomy, as well as men who
undergo non-surgical therapy such as conformal beam
radiation, seed implantation, and cryotherapy. The tissue
effects of such non-surgical treatments can often cause
strictures involving the proximal bulbar and membra-
nous urethra. At the same time, the bladder neck
becomes rigid and immobile. Hence, procedures per-
formed to open a proximal bulbar urethral stricture may
result in incontinence when the bladder neck is no
longer competent.
Medicare claims data are particularly useful in that they
allow for the estimation of the rates of diagnoses across a
large, heterogeneous, nationwide sample of the elderly
population across various clinical settings. However, the
use of claims data has several limitations. Medicare
claims provide limited clinical information, and we were
therefore unable to demonstrate a causal relationship
between urethral stricture disease and the other urologic
conditions investigated. Additionally, we do not have
data indicating whether patients had previously received
radiation or other therapy for prostate cancer, which
further complicates our ability ascertain whether inconti-
nence occurred strictly as a result of stricture disease.
Furthermore, examining claims diagnoses may be inher-
ently inaccurate in some cases. For example, bladder
neck contractures (ICD-9 code 596.0) may be mislabeled
as urethral strictures in coding, which may affect our
findings. Although not a true urethral stricture, a bladder
neck contracture occurring after radical prostatectomy is
highly associated with incontinence [16]. Opening a blad-
der neck contracture with a bladder neck incision often
unmasks incompetence of the external urethral sphincter.
Hence, coding a bladder neck contracture as a urethral
stricture may have caused us to overestimate the true
association of stricture disease with incontinence. Finally,
Medicare datasets reflect diagnoses among men age 65
and over. Our findings therefore may not be generaliz-
able to younger men with strictures.
Conclusions
Among male Medicare beneficiaries diagnosed with ure-
thral stricture disease in 2001, 42% were also diagnosed
with a urinary tract infection, and 11% with inconti-
nence. Although the overall incidence of stricture dis-
ease decreased over this time period, these rates of dual
diagnoses increased from 1992 to 2001, possibly relating
to newer and more aggressive treatments for prostate
cancer and BPH. Our findings shed light into the health
burden of stricture disease on American men. Early
urethroplasty has the potential to cure anterior urethral
strictures early, significantly decreasing the morbidity of
stricture disease described in this paper.
Additional file 1: Table S1. Male Medicare beneficiaries with a diagnosis
of urethral stricture and urinary tract infection (UTI) in the same year,
count, percent.
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Additional file 2: Table S2. Male Medicare beneficiaries with a diagnosis
of urethral stricture and urinary incontinence in the same year, count,
percent.
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